Published in Clin Diagn Lab Immunol on May 01, 2004
Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11. APMIS (2010) 1.03
Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis. Mol Med (2008) 1.02
Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression. Clin Cancer Res (2012) 0.98
Recurrent respiratory papillomatosis. Otolaryngol Clin North Am (2012) 0.92
Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis. Hum Immunol (2009) 0.91
Recurrent respiratory papillomatosis: current and future perspectives. Ther Clin Risk Manag (2015) 0.89
T(H)2-like chemokine patterns correlate with disease severity in patients with recurrent respiratory papillomatosis. Mol Med (2012) 0.83
Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosis. J Immunol (2011) 0.83
Decreased Langerhans cell responses to IL-36γ: altered innate immunity in patients with recurrent respiratory papillomatosis. Mol Med (2014) 0.80
Infection and HLA-G molecules in nasal polyposis. J Immunol Res (2014) 0.79
Immune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11. J Clin Med (2015) 0.78
Recurrent Respiratory Papillomatosis (RRP)-Juvenile Onset. Clin Med Oncol (2008) 0.77
Effects of conjugated linoleic acid and high oleic acid safflower oil in the treatment of children with HPV-induced laryngeal papillomatosis: a randomized, double-blinded and crossover preliminary study. Lipids Health Dis (2012) 0.75
Associations of FoxP3 gene polymorphisms with severe recurrent respiratory papillomatosis in Korean patients. J Otolaryngol Head Neck Surg (2017) 0.75
Lymphocyte profile and cytokine mRNA expression in peripheral blood mononuclear cells of patients with recurrent respiratory papillomatosis suggest dysregulated cytokine mRNA response and impaired cytotoxic capacity. Immun Inflamm Dis (2017) 0.75
Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol (2001) 25.63
The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today (1996) 12.12
In vivo protein transduction: delivery of a biologically active protein into the mouse. Science (1999) 10.70
Regulatory T cells: key controllers of immunologic self-tolerance. Cell (2000) 10.19
Mouse and human dendritic cell subtypes. Nat Rev Immunol (2002) 10.01
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature (1998) 9.77
CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med (2000) 7.46
Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A (1983) 6.81
A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem (1997) 6.52
Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucleic Acids Res (1992) 5.98
Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol (1982) 5.49
Dendritic cell regulation of TH1-TH2 development. Nat Immunol (2000) 5.13
Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol (1997) 5.06
Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med (1998) 4.69
The nucleotide sequence and genome organization of human papilloma virus type 11. Virology (1986) 4.04
CD28- T lymphocytes. Antigenic and functional properties. J Immunol (1993) 3.67
IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol (1998) 3.56
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature (1998) 2.98
The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol (1998) 2.27
Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proc Natl Acad Sci U S A (1982) 2.11
Th1 and Th2 in human diseases. Clin Immunol Immunopathol (1996) 2.08
TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol (1999) 2.05
Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature (1990) 1.77
Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol (1998) 1.77
Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J Exp Med (1986) 1.69
Cell-mediated immune response to human papillomavirus infection. Clin Diagn Lab Immunol (2001) 1.61
Stigma variations: observations on suppressor T cells and leprosy. Annu Rev Immunol (1992) 1.51
In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J Immunol (1998) 1.43
Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter. Cancer Res (2003) 1.40
Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Ann N Y Acad Sci (2003) 1.40
Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol (2001) 1.36
Papilloma of the larynx: a review of 109 cases with a preliminary report of aureomycin therapy. Ann Otol Rhinol Laryngol (1950) 1.35
Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity. J Immunol (2001) 1.27
Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes. J Virol (2000) 1.22
Laryngeal papillomatosis: clinical, histopathologic and molecular studies. Laryngoscope (1987) 1.18
Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors. J Leukoc Biol (1999) 1.13
Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted. Proc Natl Acad Sci U S A (1991) 1.12
Recurrent respiratory papillomatosis: altered CD8(+) T-cell subsets and T(H)1/T(H)2 cytokine imbalance. Clin Immunol (1999) 1.10
CD8Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. J Immunol (1997) 1.06
Regulation of CD28 costimulation in human CD8+ T cells. J Immunol (1997) 1.06
Human papillomavirus type 11 transcripts are present at low abundance in latently infected respiratory tissues. Virology (1995) 1.02
The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T and NK cells. J Exp Med (1994) 1.01
Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle. Clin Infect Dis (2000) 1.01
Viral latency--the papillomavirus model. Dev Biol (Basel) (2001) 0.96
Tracheal involvement in laryngeal papillomatosis. Laryngoscope (1983) 0.94
CD8(+) T cells secreting type 2 lymphokines are defective in protection against viral infection. Cell Immunol (2000) 0.94
Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein. Oncogene (1996) 0.93
Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18. FEBS Lett (2001) 0.92
Enriched HLA-DQ3 phenotype and decreased class I major histocompatibility complex antigen expression in recurrent respiratory papillomatosis. Clin Diagn Lab Immunol (1994) 0.91
Persistence and expression of human papillomavirus during interferon therapy. Arch Otolaryngol Head Neck Surg (1988) 0.89
Clinical effects of photodynamic therapy on recurrent laryngeal papillomas. Arch Otolaryngol Head Neck Surg (1992) 0.87
Genetic control of immune response and disease susceptibility by the HLA-DQ gene. Res Immunol (1992) 0.86
Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport. Clin Immunol (2001) 0.86
HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis. J Virol (2003) 0.85
Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J Immunol (1999) 0.83
Polymorphism of transporter associated with antigen presentation 1 as a potential determinant for severity of disease in recurrent respiratory papillomatosis caused by human papillomavirus types 6 and 11. J Infect Dis (2004) 0.81
The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection. J Med Primatol (1998) 0.77
Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA (2014) 2.89
Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol (2007) 1.75
Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine (2012) 1.68
The natural history of human papillomavirus infections of the mucosal epithelia. APMIS (2010) 1.61
Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection. J Allergy Clin Immunol (2008) 1.59
PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. J Gen Virol (2002) 1.23
HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis. Hum Immunol (2004) 1.09
Dye coupling among satellite glial cells in mammalian dorsal root ganglia. Brain Res (2005) 1.07
Latent Human Papillomavirus infection is comparable in the larynx and trachea. J Med Virol (2004) 1.06
Up-regulation of Rac1 by epidermal growth factor mediates COX-2 expression in recurrent respiratory papillomas. Mol Med (2007) 1.04
Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11. APMIS (2010) 1.03
Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens. J Pediatr (2005) 1.03
Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis. Mol Med (2008) 1.02
IL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease. J Immunol (2011) 1.01
Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis. Arch Otolaryngol Head Neck Surg (2005) 0.99
Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression. Clin Cancer Res (2012) 0.98
Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas. Clin Cancer Res (2005) 0.98
The effect of upper airway surgery on voice. Otolaryngol Head Neck Surg (2002) 0.95
Requirement of STAT3 activation for differentiation of mucosal stratified squamous epithelium. Mol Med (2003) 0.92
Genetic variants in TAP are associated with high-grade cervical neoplasia. Clin Cancer Res (2009) 0.92
Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis. Hum Immunol (2009) 0.91
Subcutaneous immunoglobulin infusion as an alternative to intravenous immunoglobulin. J Allergy Clin Immunol (2003) 0.88
Induction of heme oxygenase-1 and ferritin in the kidney in warm antibody hemolytic anemia. Am J Kidney Dis (2008) 0.88
Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes. Nephrol Dial Transplant (2008) 0.88
Anterior-posterior and medial compression of the supraglottis: signs of nonorganic dysphonia or normal postures? J Voice (2003) 0.86
Pak1 and Pak2 are activated in recurrent respiratory papillomas, contributing to one pathway of Rac1-mediated COX-2 expression. Int J Cancer (2010) 0.86
Constitutive overexpression of the oncogene Rac1 in the airway of recurrent respiratory papillomatosis patients is a targetable host-susceptibility factor. Mol Med (2012) 0.84
Early efficacy trial of anakinra in corticosteroid-resistant autoimmune inner ear disease. J Clin Invest (2014) 0.84
T(H)2-like chemokine patterns correlate with disease severity in patients with recurrent respiratory papillomatosis. Mol Med (2012) 0.83
Diagnostic and prognostic utility of measuring tumor necrosis factor in the peripheral circulation of patients with immune-mediated sensorineural hearing loss. Arch Otolaryngol Head Neck Surg (2012) 0.83
Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosis. J Immunol (2011) 0.83
Selective inhibition of cyclooxygenase-2 suppresses metastatic disease without affecting primary tumor growth in a murine model of Ewing sarcoma. J Pediatr Surg (2011) 0.81
Polymorphism of transporter associated with antigen presentation 1 as a potential determinant for severity of disease in recurrent respiratory papillomatosis caused by human papillomavirus types 6 and 11. J Infect Dis (2004) 0.81
Electrical compound action potentials recorded with automated neural response telemetry: threshold changes as a function of time and electrode position. Ear Hear (2011) 0.81
Adult-onset periodic fever, aphthous stomatitis, pharyngitis, and adenitis. Ann Allergy Asthma Immunol (2008) 0.80
Innate immune recognition of molds and homology to the inner ear protein, cochlin, in patients with autoimmune inner ear disease. J Clin Immunol (2013) 0.80
Phosphatidylinositol 3-kinase regulates early differentiation in human laryngeal keratinocytes. In Vitro Cell Dev Biol Anim (2005) 0.80
Interleukin 7 receptor alpha-chain-mutation severe combined immunodeficiency without lymphopenia: correction with haploidentical T-cell-depleted bone marrow transplantation. Ann Allergy Asthma Immunol (2006) 0.79
Celecoxib inhibits invasion and metastasis via a cyclooxygenase 2-independent mechanism in an in vitro model of Ewing sarcoma. J Pediatr Surg (2012) 0.79
Allergen immunotherapy practice patterns: a worldwide survey. Ann Allergy Asthma Immunol (2012) 0.79
Cyclooxygenase 2 mediates the antiangiogenic effect of rapamycin in Ewing sarcoma. J Pediatr Surg (2009) 0.79
Aberrant facial nerve. Ear Nose Throat J (2006) 0.78
Subcutaneous immunoglobulin infusion to treat infants and toddlers with antibody deficiencies. Ann Allergy Asthma Immunol (2010) 0.77
11q terminal deletion disorder and common variable immunodeficiency. Ann Allergy Asthma Immunol (2009) 0.77
Four mutations in Epidermodysplasia verruciformis 1 (EVER1) gene are not contributors to susceptibility in RRP. Int J Pediatr Otorhinolaryngol (2006) 0.77
Clinical ambiguities--ongoing questions. J Clin Immunol (2012) 0.76
A note from the editor-in-chief, deputy editor, and managing editor. J Clin Immunol (2015) 0.75